Global Plasma Fractionation Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
Request for Sample
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
MarketResearch.biz delivers in-depth insights on the global plasma fractionation market in its upcoming report titled, “Global Plasma Fractionation Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global plasma fractionation market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global plasma fractionation market report has been segmented on the basis of product type, application, end user, and region.
Blood plasma is the liquid component of whole blood, that makes up approximately 55% of the total blood volume. It comprises mainly of water, with some minerals, salts, etc. A variety of proteins such as albumin, immunoglobulins, and fibrinogen can be found in plasma. Plasma fractionation is the process of separating various components of blood plasma. Plasma fractionation is primarily used in treatment of protein deficiency in individuals and also as a packaging material for industrial applications.
Increasing use of immunoglobulins in various therapeutic applications and high prevalence rate coupled with increasing incidence of respiratory diseases and alpha-1 antitrypsin deficiency (ATTD) are major factors driving growth of the global plasma fractionation market. In addition, increasing geriatric population across the globe and high prevalence of immune disorders among them are other factors anticipated to fuel growth of the global plasma fractionation market over the forecast period.
However, high costs associated with plasma fractionation is a key factor restraining growth of the global plasma fractionation market. Additionally, limited reimbursement policies and development of alternatives for plasma fractionation are other factors expected to hamper growth of the global market over the forecast period.
Currently, the market in North America dominates the global plasma fractionation market in revenue terms owing to increasing use of immunoglobulins in neurological diseases, and availability of appropriate healthcare infrastructure in countries in the region. The market in Asia Pacific accounted for second-highest revenue share in the global plasma fractionation market, due to high expenditure for development of proper healthcare infrastructure by governments of countries, and high prevalence of hemophilia in emerging economies such as China, India, and Japan. The markets in Latin America, Europe, and Middle East & Africa are all anticipated to witness moderate growth over the forecast period. Moreover, the market in Asia Pacific is projected to witness fastest growth over the forecast period.
Global plasma fractionation market segmentation:
By product type:
- Coagulation factor concentrates
- Critical Care
By end user:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- CSL Plasma, Inc.
- Shire (BioLife Plasma Services)
- Octapharma Plasma, Inc.
- Kedrion S.p.A
- Bio Product Laboratory Ltd.
- LFB S.A.
- Biotest Pharmaceuticals Corporation
- Japan Blood Products Organization
- China Biologic Products Holdings, Inc.
Request for TOC
Don't just take our word. We are trusted by these great companies!